Эндокринология, диабет и метаболизм
1133 статей · 42 журналов
Журналы подкатегории (42)
- AACE Endocrinology and Diabetes · Elsevier (87)
- Diabetes, Obesity and Metabolism · Wiley (81)
- Endocrine Practice · Elsevier (79)
- Bone · Elsevier (70)
- Pancreatology · Elsevier (70)
- Diabetes Epidemiology and Management · Elsevier (68)
- Nutrition · Elsevier (66)
- Endocrinology & Metabolism Clinics of North America · Elsevier (54)
- The Journal of Nutritional Biochemistry · Elsevier (52)
- Endocrinología, Diabetes y Nutrición · Elsevier (50)
- Bone Reports · Elsevier (48)
- Nutrition Research · Elsevier (46)
- Metabolism · Elsevier (44)
- Endocrine and Metabolic Science · Elsevier (40)
- Endocrinology, Diabetes and Metabolism · Wiley (40)
- Obesity Research & Clinical Practice · Elsevier (38)
- Journal of Clinical Densitometry · Elsevier (35)
- Cytokine & Growth Factor Reviews · Elsevier (34)
- Growth Hormone & IGF Research · Elsevier (34)
- Best Practice & Research Clinical Endocrinology & Metabolism · Elsevier (30)
- Nature Reviews Endocrinology · Springer Nature (11)
- Journal of Clinical Hypertension · Wiley (9)
- Journal of Clinical and Translational Endocrinology · Elsevier (9)
- Journal of Diabetes · Wiley (9)
- International Journal of Obesity · Springer Nature (8)
- International Journal of Obesity Supplements · Springer Nature (8)
- npj Metabolic Health and Disease · Springer Nature (8)
- Clinical Obesity · Wiley (5)
- Acta Diabetologica · Springer Nature (0)
- BMC Endocrine Disorders · Springer Nature (0)
- BMC Nutrition · Springer Nature (0)
- Cardiovascular Diabetology · Springer Nature (0)
- Cardiovascular Diabetology – Endocrinology Reports · Springer Nature (0)
- Current Osteoporosis Reports · Springer Nature (0)
- Endocrine · Springer Nature (0)
- Hormones · Springer Nature (0)
- Journal of Bone and Mineral Metabolism · Springer Nature (0)
- Journal of Diabetes & Metabolic Disorders · Springer Nature (0)
- Journal of Endocrinological Investigation · Springer Nature (0)
- Osteoporosis International · Springer Nature (0)
- Pituitary · Springer Nature (0)
- Reviews in Endocrine and Metabolic Disorders · Springer Nature (0)
-
Real‐World Effectiveness of SGLT2i on Incident Kidney Outcomes in Patients With Type 2 Diabetes and Normoalbuminuria—A Territory‐Wide Retrospective Study
Diabetes, Obesity and Metabolism, EarlyView.
-
Testosterone Added to Incretin Therapy in Men With Overweight or Obesity: A Systematic Review of Body Composition Evidence and Gaps
Diabetes, Obesity and Metabolism, EarlyView.
-
Effects of a Prebiotic Functional Soda on Gastrointestinal Symptoms in Adults Receiving GLP‐1–Based Therapy for Weight Management: A Randomized Controlled Pilot Trial
Diabetes, Obesity and Metabolism, EarlyView.
-
Metformin in Advanced Chronic Kidney Disease: A Systematic Review and Meta‐Analysis
Diabetes, Obesity and Metabolism, EarlyView.
-
Beyond Plasma Exposure: Interpreting the Pharmacodynamic Signals of RGH‐706 for Rational Dose Selection
Diabetes, Obesity and Metabolism, EarlyView.
-
Red Cell Distribution Width Across the Glycemic Spectrum: Association and Exploratory Diagnostic Performance in Prediabetes and Type 2 Diabetes
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Prevalence of Self‐Reported Hypoglycemia and Associated Factors Among Patients With Type 1 Diabetes Mellitus Attending Follow‐Up Care at Bule Hora University Teaching Hospital, Southern Ethiopia
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Early Continuous Glucose Monitoring to Lower the Risk of Gestational Diabetes Mellitus in Women With Pre‐Pregnancy Obesity: Protocol for the Multicentre Randomised Controlled Trial (GLOW)
ABSTRACT Aims Pre‐pregnancy obesity substantially increases the risk of gestational diabetes mellitus ( GDM ), yet preventive strategies before routine GDM screening remain limited. The Glucose monitoring to Lower risk of GDM in Obese...
-
Insulin Secretion Modelling to Characterize Post‐Bariatric Hypoglycaemia After Roux‐en‐Y Gastric Bypass
ABSTRACT Aim Roux‐en‐Y Gastric Bypass (RYGB) is an effective treatment for obesity and Type 2 diabetes. Some individuals develop postprandial hypoglycaemia, termed post‐bariatric hypoglycaemia (PBH). PBH is associated with marked...
-
Managing post-bariatric weight recurrence with new obesity management medications
Nature Reviews Endocrinology, Published online: 19 November 2026; doi:10.1038/s41574-026-01324-y In this Review, the authors discuss the factors that contribute to recurrent weight gain after metabolic and bariatric surgery, treatment...
-
Therapeutic potential of GLP1RAs in diabetic sensorimotor polyneuropathy
Nature Reviews Endocrinology, Published online: 19 November 2026; doi:10.1038/s41574-026-01338-6 The introduction of glucagon-like peptide 1 receptor agonists (GLP1RAs) has transformed the care of patients with type 2 diabetes mellitus....
-
Early-life experiences and HPA axis flexibility
Nature Reviews Endocrinology, Published online: 19 November 2026; doi:10.1038/s41574-026-01331-z Early-life experiences shape lifelong flexibility of the hypothalamic–pituitary–adrenal (HPA) axis in adapting to changing environments....
-
Correlation between BMI, waist circumference, body roundness index, and a body shape index with visceral adipose tissue in the older adults: Bushehr Elderly Health Program
International Journal of Obesity, Published online: 19 November 2026; doi:10.1038/s41366-026-02247-4 Correlation between BMI, waist circumference, body roundness index, and a body shape index with visceral adipose tissue in the older...
-
Longitudinal metabolomic changes in adolescents with obesity: efficacy of a one-year ketogenic nutritional intervention
International Journal of Obesity, Published online: 18 November 2026; doi:10.1038/s41366-026-02244-7 Longitudinal metabolomic changes in adolescents with obesity: efficacy of a one-year ketogenic nutritional intervention
-
Bibliometric Insights Into Research Trends on Insulin Resistance in Gestational Diabetes Mellitus Based on the Web of Science Core Collection (1997–2025)
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
What Would Show That Strength Is Preserved During Semaglutide Weight Loss?
Diabetes, Obesity and Metabolism, EarlyView.
-
Real‐World Initiation of Resmetirom and Recorded Incretin Exposure in the United States
ABSTRACT Aims Resmetirom and semaglutide 2.4 mg are approved for metabolic dysfunction‐associated steatohepatitis but have not been tested together. We examined recorded incretin exposure among resmetirom initiators and the frequency...
-
Impact of Different Meal Types and Macronutrients on Circulating FGF21 and Appetite in Humans: A Systematic Review of Randomized Trials
ABSTRACT Introduction and Aim Fibroblast growth factor 21 (FGF21) is potentially involved in macronutrient specific appetite regulation by increasing preference for protein and suppressing preference for sugar and alcohol. The aim of...
-
What is the association between mode of delivery at birth and childhood adiposity? Findings from the Southampton Women’s Survey
International Journal of Obesity, Published online: 17 November 2026; doi:10.1038/s41366-026-02246-5 What is the association between mode of delivery at birth and childhood adiposity? Findings from the Southampton Women’s Survey
-
Imaging for localizing and therapeutic management of primary aldosteronism: the primary aldosteronism imaging outcome consensus
Nature Reviews Endocrinology, Published online: 17 November 2026; doi:10.1038/s41574-026-01325-x This Consensus Statement provides recommendations from an international group of experts on using different imaging modalities to assess...
-
Protecting brain development from thyroid hormone system-disrupting chemicals
Nature Reviews Endocrinology, Published online: 17 November 2026; doi:10.1038/s41574-026-01337-7 Protecting human development from endocrine-disrupting chemicals that affect the thyroid hormone system requires more than evaluating...
-
When the brain took control of thyroid hormone metabolism
Nature Reviews Endocrinology, Published online: 17 November 2026; doi:10.1038/s41574-026-01336-8 When the brain took control of thyroid hormone metabolism
-
Association of Continuous Glucose Monitoring‐Based Nocturnal Glucose Patterns With Microvascular Complications in Patients With Type 2 Diabetes
ABSTRACT Aims To characterize metabolic heterogeneity in Type 2 diabetes mellitus (T2DM), we used continuous glucose monitoring (CGM) data to identify nocturnal glucose patterns and examine their associations with clinical and metabolic...
-
Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study
ABSTRACT Background and Aim Postprandial reactive hypoglycaemia syndrome (PRHS) is an increasingly recognized complication after Roux‐en‐Y gastric bypass (RYGB) surgery. We investigated whether endoscopic ultrasound (EUS)‐guided bypass...
-
GLP‐1(9‐37) Improves Left Ventricular Function in a Murine Model of Cardiac Pressure Overload by Promoting Mitochondrial Biogenesis
ABSTRACT Aim Glucagon‐like peptide‐1 (GLP‐1) is an incretin hormone that is released in response to nutrient intake and inflammation. Its active form, GLP‐1(7‐37), binds to the GLP‐1 receptor (GLP‐1R), but GLP‐1 is rapidly degraded by...
-
Comparison of Sensor Accuracy for Three Different CGM‐Systems Using Either Displayed or Auto‐Logged Values in Individuals With Type 1 Diabetes Mellitus
Diabetes, Obesity and Metabolism, EarlyView.
-
Efficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 10 mg in Korean Adults With Type 2 Diabetes: A Multicentre, Randomised, Double‐Blind, Placebo‐Controlled Phase III Trial
ABSTRACT Aims To evaluate the efficacy and safety of anagliptin added to metformin and empagliflozin 10 mg in adults with Type 2 diabetes (T2D) with inadequate glycaemic control. Materials and Methods In this multicentre, randomised,...
-
MCP‐1 as a Biomarker of Vascular Function
ABSTRACT Background Endothelial dysfunction and arterial stiffness have been shown to be associated with cardiovascular disease (CVD) outcomes but assessment of these is not straightforward. CVD risk in diabetes shows heterogeneity and...
-
Efficacy of SGLT2 Inhibitors With or Without Metformin Compared With Metformin Alone in Women With Polyendocrine Metabolic Ovarian Syndrome: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Urinary Metabolic and Hemodynamic Protein Signatures in Canagliflozin Treated Patients With Diabetic Kidney Disease: Findings From CREDENCE
ABSTRACT Background Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) provide kidney protection in patients with diabetic kidney disease (DKD). There is limited knowledge about the mechanisms by which they protect the kidney. We...